The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Achieve cost savings through methods to increase clinical buy-in and adherence to supply chain decision. while maintaining a focus on clinical…
e-Learning
Updated for 2020! Begin your studies of the Supply Chain Management and Finance relationship portion within the CMRP examination with a new…
On-Demand Educational Webinars
Senior leaders within the finance/supply chain and risk management disciplines share their thoughts on the organizational and patient risks related…
On-Demand Educational Webinars
In the first half of the webinar, we will explore the Hospital PMI™, an ISM®<
White Papers
Explore your organization’s clinical integration maturity and leverage leadership involvement to make data-driven decisions.
Press Releases
CHICAGO, July 23, 2020 — In partnership with the Association for Health Care Resource & Materials Management (AHRMM) of the American Hospital A